Good day, ladies and gentlemen. Welcome to the First Quarter of Fiscal Year 2025 Financial Results Conference Call for NeuroOne Medical Technologies Corporation. Today’s call will be […] ...

The global Bunion Surgery Market, valued at US$437.8 million in 2023, is forecasted to grow at a robust CAGR of 5.7%, ...

NeuroOne Medical Technologies Corp (NMTC) reports a remarkable 235% increase in product revenue and a significant boost from its partnership with Zimmer Biomet.

From financial results to new acquisitions, here are seven key updates from spine and orthopedic devicemakers since Feb. 5.

The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of 4.8%, reaching US$23.42 billion in 2024 and an impressive US$31.09 billion by ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025Management ViewCEO Dave Rosa highlighted the strong performance ...

Stock analysts at Roth Capital issued their Q1 2025 earnings estimates for Zimmer Biomet in a research note issued on Friday, February 7th. Roth Capital analyst J. Wittes forecasts that the medical ...

Shares of Zimmer Biomet Holdings Inc. ZBH slipped 1.43% to $98.98 Tuesday, on what proved to be an all-around great trading ...

Highlights,Royal Bank of Canada adjusts Zimmer Biomet’s target price while maintaining an outperform rating.,Quarterly earnings exceed projections, reporting an EPS of $2.31 against expectations of $2 ...